| 000 | 01630 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517040754.0 | ||
| 264 | 0 | _c20161031 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1365-2265 | ||
| 024 | 7 |
_a10.1111/cen.12842 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGianatti, Emily J | |
| 245 | 0 | 0 |
_aEffect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetes. _h[electronic resource] |
| 260 |
_bClinical endocrinology _cJan 2016 |
||
| 300 |
_a55-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCoronary Disease _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aNatriuretic Peptide, Brain _xblood |
| 650 | 0 | 4 |
_aOutcome Assessment, Health Care _xmethods |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTestosterone _xanalogs & derivatives |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTroponin T _xblood |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aHoermann, Rudolf | |
| 700 | 1 | _aLam, Que | |
| 700 | 1 | _aDupuis, Philippe | |
| 700 | 1 | _aZajac, Jeffrey D | |
| 700 | 1 | _aGrossmann, Mathis | |
| 773 | 0 |
_tClinical endocrinology _gvol. 84 _gno. 1 _gp. 55-62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/cen.12842 _zAvailable from publisher's website |
| 999 |
_c25025531 _d25025531 |
||